MS
NVS icon

Maven Securities’s Novartis NVS Stock Holding History

Maven Securities’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,000
Closed -$1.52M – 396
2019
Q4 		$1.52M Hold
16,000
– – 0.14% 130
2019
Q3 		$1.39M Hold
16,000
– – 0.44% 64
2019
Q2 		$1.46M Buy
+16,000
New +$1.35M 0.97% 34
2018
Q1 		– Sell
-11,356
Closed -$860K – 82
2017
Q4 		$860K Buy
11,356
+4,660
+70% +$352K 0.44% 33
2017
Q3 		$513K Buy
+6,696
New +$506K 0.27% 29
2017
Q1 		– Sell
-5,302
Closed -$346K – 60
2016
Q4 		$346K Buy
+5,302
New +$344K 0.31% 26

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Maven Securities's NVS Position: Q1 2020 in Review

Maven Securities sold out of Novartis (NVS) in Q1 2020, closing a stake of 16,000 shares — an estimated $1.52M sold.

Maven Securities first reported a position in NVS in Q4 2016 and held it in 6 quarters. The position peaked at $1.52M in Q4 2019. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

  • Maven Securities reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
  • Maven Securities sold 16,000 Novartis shares in Q1 2020, an estimated $1.52M.
  • Maven Securities first reported a position in Novartis in Q4 2016 and held it in 6 quarters.
  • Maven Securities's Novartis position peaked at $1.52M in Q4 2019.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Maven Securities's 13F filing for Q1 2020, filed 15 May 2020.